Download Citation
Article Source:
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
Lopez-Anglada L,
Cueto-Felgueroso C,
Rosiñol L,
Oriol A,
Teruel AI,
et al.
(2018)
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
PLOS ONE 13(9): e0203392.
https://doi.org/10.1371/journal.pone.0203392